Weight Loss After Receiving Anti‐Obesity Medications and Gout Among Individuals With Overweight and Obese: A Population‐Based Cohort Study
A higher rate of weight loss after receiving treatment with orlistat within 1 year was associated with lower risks of incident gout and lower rates of recurrent gout flares among overweight or obese people.
Authors
- Junqing Xie (ORCID: https://orcid.org/0000-0002-0040-0042)
- Yuqing Zhang (ORCID: https://orcid.org/0000-0001-7638-0888)
- Chao Zeng (ORCID: https://orcid.org/0000-0003-4889-5731)
- Guanghua Lei (ORCID: https://orcid.org/0000-0003-2987-138X)
- Jie Wei (ORCID: https://orcid.org/0000-0003-3510-8241)
- Nicola Dalbeth (ORCID: https://orcid.org/0000-0003-4632-4476)
- Yilun Wang (ORCID: https://orcid.org/0000-0002-9468-4110)
- Jing Wu (ORCID: https://orcid.org/0000-0002-1112-4899)
Institutions
- Boston University (US)
- Harvard University (US)
- Central South University (CN)
- University of Auckland (NZ)
- Hunan University (CN)
- Nuffield Orthopaedic Centre (GB)
- University of Oxford (GB)
- Massachusetts General Hospital (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1002/art.42996
- Citations
- 5
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province